Co-expression of recombinant proteins

Details for Australian Patent Application No. 2001256032 (hide)

Owner Aventis Pasteur Limited

Inventors Loosmore, Sheena M; Yang, Yan-Ping

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001256032

PCT Pub. Number WO01/90383

Priority 09/577,601 25.05.00 US

Filing date 3 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 2 November 2006

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C07K 14/285 (2006.01) Peptides having more than 20 amino acids

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

Event Publications

2 November 2006 Application Accepted

  Published as AU-B-2001256032

1 March 2007 Standard Patent Sealed

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001256033-Patient oxygen delivery system

2001256031-EDGE PROTECTOR FOR COILS OF SHEET MATERIAL AND METHOD OF USE